Therefore, although we do not exclude the possibility that, in Bmal1 -/- mice, impaired insulin secretion is partly responsible for development of dyslipidemia, its contribution via acceleration of lipolysis is relatively smaller. The gene discussed is BMAL1; the disease is metabolic syndrome.